ADHD titration under Right to Choose
Titration, not assessment, is the true capacity constraint in UK ADHD services.
ADHD titration is the process of finding a safe, effective medication dose under monitoring. In England it requires a psychiatrist or independent prescriber, baseline physical checks, and structured review. It typically takes 3 to 6 months to reach a stable dose, then moves to shared care with a GP where the practice agrees.
adhd titration uk | Reviewed August 2026
| Stage | What happens | Typical duration |
|---|---|---|
| Baseline | Height, weight, blood pressure, pulse, cardiac and psychiatric history review | 1 appointment |
| Initiation | First medication started at low dose with agreed review point | 1 to 3 weeks |
| Dose adjustment | Stepwise increases with monitoring at each step | 6 to 20 weeks |
| Stabilisation | Effect and side effects reviewed, dose confirmed | 2 to 6 weeks |
| Shared care handover | Agreement offered to the GP practice, who may accept or decline | Variable |
Source: Scale Health, observed across live UK ADHD provider mandates, 2026.
Who can prescribe
ADHD medications are controlled drugs. Initiation sits with a specialist: a consultant psychiatrist, or an independent prescriber, commonly a pharmacist or nurse, working within a specialist governance framework with named supervision. This is why prescriber supply, not assessor supply, caps how many diagnosed patients a provider can actually treat.
Why shared care stalls
Once stable, the intention is that the GP prescribes under a shared care agreement while the specialist retains diagnostic oversight. Many practices decline. Reasons cited include workload, unfamiliarity with the specialist provider, and local prescribing formulary positions on independent providers.
When shared care is declined, the specialist keeps prescribing. Every retained patient permanently occupies a slice of prescriber capacity, so a provider that grows assessment volume without growing prescribing capacity gradually strangles its own pathway.
What patients should ask
Do you titrate in-house, and what is the current wait to start?
Who prescribes and who supervises them?
What happens if my GP declines shared care?
How often will I be reviewed once stable, and at what cost if any?
What providers should build
Prescriber capacity ahead of assessment volume, a supervision structure that scales with it, and a realistic model of retained caseload rather than an assumption that shared care will absorb it. Scale Health supplies independent prescribers, consultant psychiatrists and supervising clinicians into exactly this gap.
Common questions
- How long does ADHD titration take?
- Typically 3 to 6 months from first dose to a stable, reviewed dose, depending on response, side effects and how often review appointments are available.
- Is titration free under Right to Choose?
- Where the provider delivers NHS-funded titration, yes, aside from standard England prescription charges. Some providers assess under NHS funding but charge privately for titration, so check first.
- Can a pharmacist prescribe ADHD medication?
- Yes. Pharmacist independent prescribers routinely run titration within a specialist governance framework with named psychiatric supervision.
- What if my GP will not take over prescribing?
- The specialist provider continues to prescribe and monitor. Shared care is voluntary for GPs and refusal does not affect your diagnosis or treatment.
Keep reading
Right to Choose ADHD assessment
Assessment is no longer the hard part. Getting medication titrated and shared care accepted is where the pathway breaks.
ReadRight to Choose waiting times in 2026
Quoted waits are a capacity readout. When a provider's wait doubles, it almost always means a clinician left, not that demand spiked.
ReadScaling a Right to Choose service
Growth in this market is gated by three roles, and only one of them is easy to hire.
ReadExplore next
Running a Right to Choose service?
Scale Health builds the clinical benches these pathways depend on: assessors, independent prescribers, supervising clinicians and consultant psychiatrists, credentialed before they start.